Optimal follow-up strategy using high-risk HPV testing and cytology after conservative treatment for cervical adenocarcinoma in situ [0.03%]
宫颈原位腺癌保守治疗后采用高危型HPV检测和细胞学筛查的最优随访策略
M Schaafsma,T N Schuurman,I S van Maurik et al.
M Schaafsma et al.
Objective: After treatment for cervical adenocarcinoma in situ (AIS) patients remain at risk for recurrent AIS, high-grade cervical intraepithelial neoplasia, and cervical carcinoma (combined AIS/CIN3+). This study aimed ...
Enhancing the Understanding of Female Sexual Function in Fertility Research [0.03%]
提高女性性功能在生育研究中的认识水平
Hongnan Shen,Jinguo Cheng
Hongnan Shen
Active surveillance of cervical intraepithelial neoplasia grade 2 is not associated with an increased risk of non-cervical anogenital HPV-related cancer and precancer a population-based cohort study [0.03%]
一项基于人群的队列研究：宫颈上皮内瘤变2级的主动监测不会增加非宫颈肛门生殖器HPV相关癌和癌前病变的风险
Dina O Eriksen,Kathrine D Lycke,Johnny Kahlert et al.
Dina O Eriksen et al.
Background: In recent years, many countries have implemented active surveillance (i.e., leaving the lesion untreated) as an option in younger women with cervical intraepithelial neoplasia grade 2 instead of excisional tre...
Preconception and first trimester metformin on pregnancy outcomes in women with polycystic ovary syndrome: a systematic review and meta-analysis [0.03%]
二甲双胍对多囊卵巢综合征女性妊娠结局的影响：系统评价和网状Meta分析
James Cheshire,Akanksha Garg,Paul Smith et al.
James Cheshire et al.
Objective: To explore the effects of preconception and first trimester metformin use on pregnancy outcomes in women with polycystic ovary syndrome (PCOS). ...
Glucagon-like peptide-1 receptor agonist and adverse obstetrical outcomes [0.03%]
胰高血糖素样肽-1受体激动剂与不良产科结局的关系
Alexandra Regens,Alireza Danesh,Zachary Fennell
Alexandra Regens
Reevaluating the Link Between Birthweight and Postpartum Hemorrhage: The Overlooked Role of Gestational Diabetes in India [0.03%]
重新评估出生体重与产后出血之间联系：印度妊娠糖尿病的 overlooked 角色
Nidhi Basavaraj
Nidhi Basavaraj
Expanded Discussion of Limitations for Impact of Glucagon-like peptide-1 Receptor Agonist Use Association with Decreased Risk of Adverse Obstetrical Outcomes [0.03%]
关于 glucagon-like肽-1受体激动剂使用与降低不良妊娠结局风险关联的局限性讨论扩展
Marisa R Imbroane,Felicia LeMoine,Christopher T Nau
Marisa R Imbroane
Roni Zemet,Ronald J Wapner,Ignatia B VAN DEN Veyver
Roni Zemet